Atıf İçin Kopyala
Pamukcuoglu M., Emmez H., GÜZEL TUNÇCAN Ö., ÖNER A. Y., Cirak M. Y., ŞENOL E., ...Daha Fazla
HEMATOLOGY, cilt.19, sa.3, ss.158-162, 2014 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
19
Sayı:
3
-
Basım Tarihi:
2014
-
Doi Numarası:
10.1179/1607845413y.0000000108
-
Dergi Adı:
HEMATOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.158-162
-
Anahtar Kelimeler:
Multiple myeloma, Brain abscess, Nocardia infection, Bortezomib, HEPATITIS-B REACTIVATION, HERPES-ZOSTER, BORTEZOMIB, IMMUNODEFICIENCY, INVOLVEMENT, RISK
-
Gazi Üniversitesi Adresli:
Evet
Özet
Objective and importance: Introduction of high-dose chemotherapy and the novel agents including bortezomib, Lenalidomide, and Thalidomide has provided a significant progress in the treatment of multiple myeloma (MM) with an increase in median overall survival up to 6-8 years. However, the advances in myeloma treatment comes at a price with new spectrum of treatment-related infectious complications which should be taken into consideration while treating these patients.